Aethlon Medical (AEMD) Common Equity (2011 - 2026)

Aethlon Medical's Common Equity history runs 16 years deep, the most recent figure standing at $4.9 million for Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 4.63% year-over-year to $4.9 million; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (down 4.63% YoY), and the FY2026 full-year result was $4.9 million, down 4.63% from the prior year.
• Common Equity was $4.9 million for Q1 2026 at Aethlon Medical, down from $6.7 million in the prior quarter.
• Over the last five years, Common Equity for AEMD reached as high as $19.9 million in Q3 2022 and fell as low as $3.4 million in Q2 2025.
• Median Common Equity over the past 5 years was $7.6 million (2023), compared with a mean of $9.8 million.
• Across the five-year window, Common Equity soared 82.83% in 2022 and plunged 61.72% in 2024, its largest moves.
• Over 5 years, Common Equity stood at $17.3 million in 2022, then plunged by 55.95% to $7.6 million in 2023, then slumped by 43.06% to $4.3 million in 2024, then surged by 54.89% to $6.7 million in 2025, then declined by 27.21% to $4.9 million in 2026.
• Business Quant data shows AEMD's Common Equity at $4.9 million in Q1 2026, $6.7 million in Q4 2025, and $5.7 million in Q3 2025.